Description
Linvesta 5 mg Tablets contain linagliptin, a DPP-4 inhibitor used in the management of type 2 diabetes mellitus. Linagliptin works by enhancing insulin secretion and decreasing glucose production in the liver, which helps to control blood sugar levels more effectively.
Dosage/Direction:
The usual dose is 1 tablet (5 mg) taken once daily, with or without food. The dosage should be consistent and as directed by your healthcare provider. Regular monitoring of blood glucose levels is important to ensure effective management of diabetes.
Side Effects:
Common side effects include upper respiratory tract infections, headache, and gastrointestinal symptoms such as nausea. Rare but serious side effects may include pancreatitis or severe allergic reactions. Contact your healthcare provider if you experience severe or persistent symptoms.
